# Lofexidine for Adults Undergoing Lumbar Spine Surgery

> **NCT04126083** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Opioid Withdrawal

## Interventions

- **DRUG:** Lofexidine Oral Tablet

## Key facts

- **NCT ID:** NCT04126083
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2021-04-15
- **Final completion:** 2021-04-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04126083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04126083, "Lofexidine for Adults Undergoing Lumbar Spine Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04126083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*